Severe respiratory syncytial virus infections and reduced interferon-γ generation in vitro

Clinical and Experimental Immunology

Volumn 138, Issue 1, 2004, Pages 102-109

  Schauer, Uwe ^a,b   Hoffjan, S ^a   Rothoeft, T ^a   Bartz, H ^a   Konig S ^a   Fuchs, E ^a   Bittscheidt, J ^a   Kochling A ^a   Stephan, V ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

Author keywords

Bronchiolitis; Dendritic cells; Interferon type II; Respiratory syncytial virus infections; T lymphocytes

Indexed keywords

CD35 ANTIGEN RECEPTOR; CD4 ANTIGEN; CD45 ANTIGEN; GAMMA INTERFERON; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR CHAIN V BETA2; TOXIC SHOCK SYNDROME TOXIN 1; UNCLASSIFIED DRUG;

ARTICLE; BRONCHIOLITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; INFANT; INTERFERON PRODUCTION; LYMPHOCYTE CULTURE; MALE; NEWBORN; NONHUMAN; NORMAL HUMAN; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; VIRUS CELL INTERACTION; VIRUS INFECTION;

BACTERIAL TOXINS; BRONCHIOLITIS; CELLS, CULTURED; CHILD, PRESCHOOL; DENDRITIC CELLS; ENTEROTOXINS; FETAL BLOOD; HUMANS; INFANT; INTERFERON TYPE II; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SEVERITY OF ILLNESS INDEX; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 4644306152     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02582.x     Document Type: Article

References (38)

1. Johnston SL. The role of viral and atypical bacterial pathogens in asthma pathogenesis. Pediatr Pulmonol Suppl 1999; 18:141-3.
2. McIntosh K, Ellis EF, Hoffman LS, Lybass TG, Eller JJ, Fulginiti VA. The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr 1973; 82:578-90.
3. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140:543-6.
4. Simoes EA. Respiratory syncytial virus infection. Lancet 1999; 354:847-52.
5. Renzi PM, Turgeon JP, Marcotte JE et al. Reduced interferon-gamma production in infants with bronchiolitis and asthma. Am J Respir Crit Care Med 1999; 159:1417-22.
6. Roman M, Calhoun WJ, Hinton KL et al. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997; 156:190-5.
7. Aberle JH, Aberle SW, Dworzak MN et al. Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am J Respir Crit Care Med 1999; 160:1263-8.
8. Beyer M, Bartz H, Horner K, Doths S, Koerner-Rettberg C, Schwarze J. Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection. J Allergy Clin Immunol 2004; 113:127-33.
9. Steinman RM, Inaba K, Turley S, Pierre P, Mellman I. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum Immunol 1999; 60:562-7.
10. Klagge I, Schneider-Schaulies S. Virus interactions with dendritic cells. J Gen Virol 1999; 80:823-33.
11. Bartz H, Türkel Ö, Hoffjan S, Rothoeft T, Gonschorek A, Schauer U. Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naïve T cells. Immunology 2003; 109:49-57.
12. Schauer U, Hoffjan S, Bittscheid J et al. Respiratory syncytial virus bronchiolitis and risk of wheeze and allergic sensitization in the first year of life. Eur Respir J 2002; 20:1277-83.
13. Bartz H, Büning-Pfaue F, Türkel Ö, Schauer U. Respiratory syncytial virus (RSV) induces prostaglandin E2 (PGE2), IL-10 and IL-11 generation in antigen presenting cells. Clin Exp Immunol 2002; 129:438-45.
14. Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med 1999; 189:821-9.
15. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Meth 1993; 159:197-207.
16. Matsuse H, Behera AK, Kumar M, Rabb H, Lockey RF, Mohapatra SS. Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness. J Immunol 2000; 164:6583-92.
17. Kumar M, Behera AK, Matsuse H, Lockey RF, Mohapatra SS. Intra-nasal IFN-gamma gene transfer protects BALB/c mice against respiratory syncytial virus infection. Vaccine 1999; 18:558-67.
18. Behera AK, Kumar M, Lockey RF, Mohapatra SS. 2′-5′ oligoadenylate synthetase plays a critical role in interferon-gamma inhibition of respiratory syncytial virus infection of human epithelial cells. J Biol Chem 2002; 277:25601-8.
19. Beverley PC. Functional analysis of human T cell subsets defined by CD45 isoform expression. Semin Immunol 1992; 4:35-41.
20. + T cell subsets in adult allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant 2003; 32:609-16.
21. + T cell memory, CD45R subsets and the persistence of antigen - a unifying concept. Immunol Today 1998; 19:60-4.
22. Spann KM, Tran KC, Chi B, Rabin RL, Collins PL. Suppression of the induction of alpha, beta, and gamma interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J Virol 2004; 78:4363-9.
23. Valarcher JF, Furze J, Wyld S, Cook R, Conzelmann KK, Taylor G. Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J Virol 2003; 77:8426-39.
24. Parronchi P, Mohapatra S, Sampognaro S et al. Effects of interferon-alpha on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergen-specific T cells. Eur J Immunol 1996; 26:697-703.
25. Pala P, Bjarnason R, Sigurbergsson F, Metcalfe C, Sigurs N, Openshaw PJ. Enhanced IL-4 responses in children with a history of respiratory syncytial virus bronchiolitis in infancy. Eur Respir J 2002; 20:376-82.
26. Vieira PL, de Jong EC, Wierenga EA, Kapsenberg ML, Kalinski P. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J Immunol 2000; 164:4507-12.
27. Papadopoulos NG, Stanciu LA, Papi A, Holgate ST, Johnston SL. A defective type 1 response to rhinovirus in atopic asthma. Thorax 2002; 57:328-32.
28. Brooks GD, Buchta KA, Swenson CA, Gern JE, Busse WW. Rhinovirus-induced interferon-gamma and airway responsiveness in asthma. Am J Respir Crit Care Med 2003; 168:1091-4.
29. Bont L, Heijnen CJ, Kavelaars A et al. Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis. Eur Respir J 1999; 14:144-9.
30. Bont L, Heijnen CJ, Kavelaars A et al. Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis 2001; 184:355-8.
31. Hall CB, Douglas RG Jr, Schnabel KC, Geiman JM. Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun 1981; 33:779-83.
32. Marshall GD Jr, Agarwal SK, Lloyd C, Cohen L, Henninger EM, Morris GJ. Cytokine dysregulation associated with exam stress in healthy medical students. Brain Behav Immun 1998; 12:297-307.
33. Hoffjan S, Ostrovnaja I, Nicolae D et al. Genetic variation in immunoregulatory pathways and atopic phenotypes in infancy. J Allergy Clin Immunol 2004; 113:511-18.
34. Hoebee B, Rietveld E, Bont L et al. Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. J Infect Dis 2003; 187:2-11.
35. Choi EH, Lee HJ, Yoo T, Chanock SJ. A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis 2002; 186:1207-11.
36. Hoebee B, Bont L, Rietveld E et al. Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis. J Infect Dis 2004; 189:239-47.
37. Polack FP, Karron RA. The future of respiratory syncytial virus vaccine development. Pediatr Infect Dis J 2004; 23(Suppl. 1):S65-73.
38. Handforth J, Sharland M, Friedland JS. Prevention of respiratory syncytial virus infection in infants. Br Med J 2004; 328:1026-7.